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Temporomandibular disorders (TMDs) include 
several musculoskeletal and neuromuscular 
diseases involving the temporomandibular joint 
(TMJ), masticatory muscles and/or other associated 
structures.[1] Muscle-related TMD could be classified 
according to the Diagnostic Criteria for TMDs 
(DC/TMD)[1] as myalgia, tendonitis, myositis, and 
spasm. Myalgia can be further categorized into the 
following groups: local myalgia, myofascial pain, and 
myofascial pain with referral.
Myofascial pain is one of the most common 
causes of TMD,[2] affecting 85% of general population 
during their lifetime with an overall prevalence 
of approximately 46%.[3] Patients affected by 
myofascial pain have commonly a depressive state, 
lower independence in activities of daily living 
(ADLs), and an overall lower health-related quality 
of life (HRQoL).[4,5] Although the exact inf luence 
of myofascial pain is still unclear, several factors 
have been proposed to involve in the pathogenesis 
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ABSTRACT
Objectives: This study aims to evaluate the effectiveness of upper Michigan occlusal splint (OS) compared to mandibular OS in terms of 
pain, range of motion (ROM), and muscle activity as assessed by surface electromyography (sEMG) in patients affected by muscle-related 
temporomandibular disorders (TMD).
Patients and methods: In this randomized-controlled trial, a total of 40 adult patients (13 males, 27 females; mean age: 47.2±12.8 years; 
range, 22 to 56 years) with a diagnosis of myofascial pain, lasting from at least three months on at least one masseter muscle. The patients 
were randomly allocated into two groups: Group 1 (n=20) using upper Michigan OS and Group 2 (n=20) using mandibular OS. At baseline 
(T0), at one (T1), three (T2), and six months (T3), the following outcomes were assessed: myofascial pain by Visual Analog Scale (VAS) 
and ROM of mandible movements, activity of the main masticatory muscles through sEMG.
Results: There were no significant intra-group differences in the outcome measures assessed in both groups. However, Group 2 had a 
significantly higher right lateral mandibular ROM at T2 (7.1±3.1 vs. 9.8±2.3, respectively; p<0.05) and a significantly higher left lateral 
mandibular ROM at T3 (7.6±3.5 vs. 10.5±2.1, respectively; p<0.05). We found no significant difference in none of the sEMG parameters.
Conclusion: Our study results suggest that OS, independently from being built on the upper or lower arch, seems to not have significant 
effects in reducing pain over a six-month period in TMD patients.
Keywords: Electromyography, myofascial pain syndrome, occlusal splint, pain management, rehabilitation, temporomandibular joint disorder.
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including overuse of a normally perfused muscle, 
ischemia of a normally working muscle, sympathetic 
ref lexes that lead to changes in vascular supply, and 
altered psychological and emotional states, shared 
with fibromyalgia syndrome.[6,7]
Myofascial pain is commonly treated by 
analgesic and/or anti-inf lammatory drugs, occlusal 
splints (OS), injections of botulinum type A toxin, 
instrumental physical therapies, and dry needling 
and trigger points injections.[8-12] In this scenario, 
OS may provide centric relation occlusion, eliminate 
posterior interferences, reduce neuromuscular 
activity, and obtain stable occlusal relationships 
with uniform tooth contacts throughout the dental 
arch.[13] Mandibular OS[14-16] and upper Michigan 
OS[17-19] are two of the OS approaches most commonly 
used in the treatment of TMDs. Although these 
treatments have already been extensively described 
in literature,[8,9,14-19] with a moderate-to-very low 
quality evidence supporting their effectiveness 
in the treatment of TMDs,[8] there are no data 
available comparing between the effects of these 
two approaches in terms of reduction of pain in 
muscle-related TMD patients. In the present study, 
therefore, we aimed to evaluate the effects of the 
upper Michigan OS compared to a mandibular f lat 
OS in terms of reducing pain, improving range of 
motion (ROM), and changing muscle activity in 
patients affected by myofascial TMD.
PATIENTS AND METHODS
In this randomized-controlled trial (RCT), we 
recruited adult patients consecutively referring to a 
Gnathology Unit of a tertiary care hospital between 
January 2018 and June 2019. Inclusion criteria were 
as follows: having a diagnosis of myofascial pain 
according to the DC/TMD;[1] a Visual Analog Scale 
(VAS) score of ≥4; and pain lasting from at least three 
months on at least one masseter muscle. Exclusion 
criteria were as follows: having a history of TMJ disc 
displacement or arthralgia or osteoarthritis; having 
a history of head trauma; previous or concomitant 
treatment with oral splint; presence of oral removable 
prosthesis; drug addiction; allergy to acrylic resin; 
ongoing anti-inf lammatory or rehabilitative 
treatments; high risk of obstructive sleep apnea 
syndrome as assessed by Stop-Bang questionnaire;[20] 
having a history of mental problems; and having 
Figure 1. Study flow chart.
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a history of therapy for bruxism. Finally, out of 
56 patients with painful myofascial TMD, a total of 
40 adult patients (13 males, 27 females; mean age: 
47.2±12.8 years; range, 22 to 56 years) who met the 
inclusion criteria were included in the study. The study 
f low chart is shown in Figure 1. A written informed 
consent was obtained from each patient. The study 
protocol was approved by the AOU Città della Salute 
e della Scienza di Torino Ethics Committee (Date: 
12/09/2016, No: 0089207). The study complied with 
conducted in accordance with the principles of the 
Declaration of Helsinki and pertinent national and 
international regulatory requirements.
Intervention
The patients were randomly allocated in a 1:1 
ratio into two groups by an independent investigator 
using an online software (www.random.org, Dublin, 
Ireland): upper Michigan OS (Group 1, n=20) and 
mandibular OS (Group 2, n=20).
In Group 1, the OS was in contact with the 
mandibular supporting cusps and had cuspid guidance 
discluding the supporting cusp contact almost as soon 
as lateral or protrusive mandibular movements were 
made.[17] In Group 2, the OS was constructed to allow 
only posterior contacts (from the second premolar 
to the second/first permanent molar), without static 
and dynamic anterior contacts,[16] following the 
biomechanical models proposed by Ferrario et al.[15] 
All patients underwent the treatment with OS during 
night time, for at least 8 h per night for a total of six 
months.
Outcomes
The primary outcome of this study was the 
reduction of myofascial pain as assessed by the VAS. 
The secondary outcomes were the ROM of mandible 
movements and the activity of the main masticatory 
muscles (superficial masseter and anterior temporalis) 
as evaluated by surface electromyography (sEMG). 
All outcome measures were assessed at baseline (T0), 
one month (T1), three months (T2), and six months 
(T3) by a single observer who was unblinded to the 
problems of the patients and experienced in the 
diagnosis and treatment of TMD according to the 
DC/TMD.[1]
Instruments
The VAS is used to evaluate the intensity of 
myofascial pain perceived by the patient at the clinical 
evaluation, scoring from 0 (no pain) to 10 (worst pain 
ever).
The ROM was assessed for the following mandible 
movements:
 - Active opening (AO): measured from the right 
lower central incisor margin to the right upper 
central incisor margin, when the patients 
carried out a maximum mouth opening 
without feeling pain;
 - Passive opening (PO): measured from the right 
lower central incisor margin to the right upper 
central incisor margin, when the patients 
carried out a maximum mouth opening, while 
the clinician was forcing the AO; 
 - Protrusion (PR): measured from the upper 
incisor and the lower incisor, when the patients 
carried out the PR movement;
 - Lateral excursion mandibular movement (LAT): 
measured from the superior interincisal line to 
the inferior interincisal line, when the patients 
carried out left and right lateral excursion 
mandibular movements.
The sEMG was also used to assess the main 
masticatory muscles (superficial masseter and 
anterior temporalis) activity using the Foremg® device 
(4T QuattroTi S.r.l. Cislago, Varese, Italy), and the 
OTBioLab® software (OT Bioelettronica, Torino, Italy). 
The concentric bipolar electrodes (CoDe®: Concentric 
Detection, OT Bioelettronica, Torino, Italy) were used 
to detect the myoelectric activity.[21,22]
To reduce skin impedance, the skin was carefully 
cleaned with antiseptic gel prior to electrodes 
placement, and recordings were performed 5 to 6 min 
later, allowing the conductive paste to adequately 
moisten the skin surface.[23] Electromyographic 
recordings were performed before and after splint 
treatment pacing electrodes by palpation of the muscle 
in the main direction of the muscle fibers,[24] and 
accordingly to anatomical references described.[25] The 
EMG activity of jaw elevator muscles was detected with 
disposable bipolar silver chloride (AgCl) concentric 
electrodes using a 16-mm radius applied on the muscles’ 
bellies, while a reference electrode was applied on the 
forehead.[26] The EMG activity was recorded using four 
of the eight channels of the instrument. The analogic 
EMG signal was amplified, digitized, and digitally 
filtered. The signals were sampled at 800 Hz with 8-bit 
resolution. The EMG channels were filtered between 
10 and 400 Hz with a gain of 4,300. The instrument 
was directly interfaced with a computer that presented 
the data graphically and recorded them for further 
quantitative and qualitative analyses.
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During the recordings, the patients sat with their 
heads unsupported and were asked to maintain 
a natural erect posture with open eyes, with feet 
positioned on the f loor, hands were resting on their 
legs. Four recordings were performed during this 
study. All measurements were done using the same 
electrodes positioned in the same cutaneous area, 
using same cables and oral appliance, to reduce 
biological and technical noise. The patients were 
asked to relax for 3 min between each recording to 
avoid fatigue.
A series of sEMG indices[27-29] were used to perform 
the evaluation of the muscular activity. The indices 
were computed as follows:
1. Percentage overlapping coefficient (POC):[27] 
an index of the symmetric distribution of 
muscular activity as determined by occlusion, 
calculated for each couple of homologous 
muscles, anterior temporal and superficial 
masseter; its ranges from 0% (no symmetry) 
to 100% (perfect symmetry), where a POC of 
>85% is considered normal.
2. Barycenter (BAR):[27] an index providing data 
on the principal occlusal center of pressure, 
calculating to compare the muscle activity of 
masseter and temporalis muscles; the occlusal 
center of pressure (clench on the occlusal 
surfaces compared to clench on the cotton 
rolls) may be displaced onwards (temporalis 
prevalence) or backwards (masseter 
prevalence); it ranges from -100% (temporalis 
muscle prevalence) to +100% (masseter muscle 
prevalence).
3. Impact coefficient (IMPACT):[27] a measure of 
the total electrical activity, by calculating the 
area under the muscular waveforms of all four 
analyzed muscles; it assesses the muscle work 
performed during the selected task.
4. Torque coefficient (TC):[28] an index computed 
in case of an unbalanced contractile activity of 
contralateral masseter and temporalis muscles, 
ranging from 0% (unbalanced standardized 
masseter and temporalis potentials) to 100% 
(well comparable standardized masseter and 
temporalis potentials).
5. Asymmetry index (ASIM):[29] an index that 
quantifies the asymmetrical masticatory 
muscle activity to identify the dominant side; it 
ranges from -100% to +100%, where a negative 
number indicates a left-side muscle dominance 
and a positive number a right-side one.
Statistical analysis
Considering the VAS as the primary outcome and 
taking into account an effect size of 1.3 as described 
by Keskinruzgar et al.,[30] the minimum sample size 
was calculated as 11 patients per group. Considering 
a 10% dropout rate, 24 patients (12 in each group) 
were needed. The null hypothesis was defined as: 
H0: μ1= μ2, indicating that media variations of all 
analyzed variables must be the same in the two 
different study groups. The null hypothesis can be 
rejected, if some of the variables reached statistical 
significance. The power of the study was 90% with a 
type I error level of 0.05.
Statistical analysis was performed using the IBM 
SPSS version 23.0 software (IBM Corp., Armonk, 
NY, USA). Continuous variables were presented in 
mean ± standard deviation or median (min-max), 
while categorical variables were expressed in number 
and frequency. The Shapiro-Wilk test was performed 
to assess the distribution of all continuous data, 
as the data did not show a normal distribution. 
The differences between single variables at different 
timepoints were assessed by the two-way Friedman 
Analysis of Variance (ANOVA) for repeated measures 
and Dunn’s post-hoc test. The Wilcoxon rank-sum test 
was used to compare continuous variables between the 
two groups at different timepoints. A p value of <0.05 
was considered statistically significant.
RESULTS
All patients completed the treatment without any 
withdrawal. The mean age was 46.0±14.8 years in 
Group 1 and 48.5±10.6 years in Group 2. There was 
no statistically significant difference in the baseline 
demographic characteristics between the groups.
We observed a trend in decreasing pain as 
assessed by VAS in both groups, particularly after 
six months (T3-T0) of the Michigan OS treatment 
(mean VAS: 5.1±2.5 vs. 3.9±1.6, respectively; p=0.061); 
however, there were no statistically significant 
intra- or inter-group differences in the VAS scores. 
As depicted in Table 1, there were no significant 
intra-group differences in all the other outcome 
measures. However, Group 2 had a significantly higher 
mean right lateral mandibular ROM at T2 (7.1±3.1 
vs. 9.8±2.3, respectively; p<0.05) and a significant 
higher left lateral mandibular ROM at T3 (7.6±3.5 
vs. 10.5±2.1, respectively; p<0.05). In addition, no 
significant inter- and intra-group differences were 
observed in any sEMG parameters (Table 2).
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No side effect or compliance problem were reported 
with the use of splints which were also prescribed at 
the end of the study.
DISCUSSION
Myofascial pain adversely affects ADLs and HRQoL 
of TMD patients. Therefore, several treatments can 
be applied to reduce the invaliding pain, including 
pharmacological therapy, rehabilitative treatments, 
instrumental physical therapies, and OS.[8-12]
In this study, we compared the effects of both 
upper Michigan OS and mandibular splint in terms 
of myofascial pain, ROM, and muscle activity in 
TMD patients. Our study results showed that OS, 
independently from being built on the upper or lower 
arch, had no significant effects in reducing pain over a 
six-month period in TMD patients. Nonetheless, it was 
interesting to notice that no side effects were reported 
by the study participants and their compliance to OS 
prescription was successful as testified by no dropouts 
throughout the study period.
Although there were no significant inter- and 
intra-group differences for all the considered 
outcomes, we noticed a trend in decreasing pain 
in patients of both groups. It should be considered 
that pain-related TMDs embracing clinical problems 
involving the masticatory system, the TMJ, may 
also impact HRQoL in these subjects.[31,32] In a 
recent systematic review, Dahlström and Carlsson[33] 
reported that subjective TMD symptoms, including 
myofascial pain, had a greater impact than clinical 
findings on the oral health-related quality of life 
(OHRQoL). Indeed, TMDs have a greater impact 
compared to other diseases which may affect the oral 
health status, thus leading to a poor OHRQoL.[33-36]
To date, although the widely recognized 
application of OS for treating TMDs is in use in 
patients with muscle-related disorders,[8,9,37-39] there 
are no head-to-head studies comparing the effects of 
upper and lower OS. In a recent study, Al-Moraissi et 
al.[8] performed a network meta-analysis of 48 RCTs 
to assess the effectiveness of various types of OS in 
the management of TMD and found that there was 
moderate-to-very low-quality evidence supporting 
the effectiveness of OS combined to counselling 
therapy to achieve the maximum improvement for 
TMD patients. On the contrary, findings of our RCT 
did not confirm a reduction in terms of pain after 
treatment in both upper Michigan and mandibular 
OS groups after six months of treatment. The splint-
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the masseter and temporal muscles has been also 
reported by other authors,[40,41] and even if it cannot 
be presented statistically and clinically related to 
the reduction in TMD pain, it is believed to play an 
important role in this effect.[15] However, Zhang et 
al.[42] performed a double-blind, RCT in 36 patients 
with myofascial pain and confirmed that OS could 
have a significant positive effect on clinical outcomes. 
Furthermore, the authors showed, by sEMG analysis, 
that the wearing of OS might reduce fatigue in the 
masticatory muscles with a correlation between the 
OS treatment and electromyographic changes in the 
masticatory muscles; however, their findings were 
effective only in the short-term, considering that the 
follow-up visit was at one month from the beginning 
of OS treatment. Other studies also confirmed 
an improvement in sEMG parameters in both the 
masseter and the temporal muscles after treatment 
with OS.[43,44] On the other hand, in our study, as far 
as electromyography is concerned, we found only a 
trend, albeit not significant, in changing of sEMG 
parameters after OS treatment, compared to baseline.
Nonetheless, there are some limitations to this study. 
First, the study was conducted during a six-month 
period which could provide us the short- or mid-term 
results of OS use. Second, in our study, no counselling 
therapy was given to the patients, which was recently 
demonstrated by Al-Moraissi et al.[8] to produce, in 
combination with OS, the maximum improvement 
for patients affected by TMD. Third, there is a lack of 
control group not undergoing splint therapy, that could 
better point out the effects of upper Michigan and lower 
mandibular OS. However, we initially hypothesized 
that both methods would be effective in TMD patients, 
as shown in many previous studies.[14-19] Nevertheless, 
to the best of our knowledge, this is the first RCT 
comparing the effects of upper Michigan and lower 
mandibular OS in reducing myofascial pain and on 
muscle activity as assessed by sEMG.
In conclusion, the findings of the present 
study suggested that a 6-month treatment with 
OS, independently from being built on the upper 
or lower arch, seems to not have significant effects 
in reducing myofascial pain in patients affected by 
muscle-related TMD. Future large-scale, prospective 
studies with a longer follow-up should be performed 
to gain a better understanding of the effectiveness 
of OS in these patients. Based on our results, we 
suggest that the treatment of muscle-related TMDs 
should be multifactorial including OS, analgesic 
drugs, psychological support, and an adequate and 
patient-tailored rehabilitation.
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